Remote Monitoring for Implantable Cardiac Electronic Devices

Heart Lung and Circulation

Volumn 21, Issue 6-7, 2012, Pages 352-357

  Young, Glenn D ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Implantable defibrillator; Pacemaker; Remote monitoring

Indexed keywords

ARTICLE; AUSTRALIA; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; DEFIBRILLATOR; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOME MONITORING; HUMAN; MOBILE PHONE; NEW ZEALAND; PACEMAKER; PATIENT SAFETY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROCESS DESIGN; REMOTE SENSING; TELEMONITORING; TREATMENT OUTCOME;

DEFIBRILLATORS, IMPLANTABLE; HUMANS; PACEMAKER, ARTIFICIAL; REMOTE SENSING TECHNOLOGY;

EID: 84862181275     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2012.03.007     Document Type: Article

References (14)

1. Mond H., Whitlock R. The Australian and New Zealand cardiac pacing and implantable cardioveter-defibrillator survey: calendar year 2009. Heart, Lung and Circulation 2011, 20:99-104.
2. Department of Broadband, Communications and the Digital Economy. http://www.dbcde.gov.au/mobile_services/mobile_phones.
3. Crossley G., Boyle A., Vitense H., Chang Y., Mead R.H. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial. Journal of the American College of Cardiology 2011, 57:1181-1189.
4. Varma N., Epstein A., Irimpen A., Schweikert R., Love C. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defribrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (Trust) trial. Circulation 2010, 122:325-332.
5. Nielsen J., Kottkamp H., Zabel M., Aliot E., Kreutzer U., Bauer A., et al. Automatic home monitoring of implantable cardioverter defibrillators. Europace 2008, 10:729-735.
6. Hauser R., Maisel W., Friedman P., Kallinen L.M., Mugglin A.S., Kumar K., et al. Longevity of sprint fedelis implantable cadioverter-defibrillator leads and risk factor for failure: implications for patient management. Circulation 2011, 123:356-363.
7. Simons E., Feigenblum D., Nemirovsky D., Simons G.R. Alert tones are frequently inaudible among patients with implantable cardioverter-defibrillators. Pacing and Clinical Electrophysiology 2009, 32:1272-1275.
8. Bennett M., Kerr C., Hahn E., Flavelle S., McIlroy C., Tung S.K. Characteristics of patients and implantable defibrillators associated with failure to sense device alert systems. Europace 2010, 12:1571-1573.
9. Spencker S., Coban N., Koch L., Schirdewan A., Muller D. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace 2009, 10:483-488.
10. Mascioli G., Curnis A., Landolina M., Klersy C., Gelmini G.P., Ruffa F. Actions elicited during scheduled and unscheduled in-hospital follow-up of cardiac devices: results of the ATHENS multicentre registry. Europace 2011, 13:1-8.
11. Heidbüchel H., Lioen P., Foulon S., Huybrechts W., Ector J., Willems R., et al. Potential role of remote monitoring for scheduled and unschedules evaluations of patients with an implantable defibrillator. Europace 2009, 10:351-357.
12. Stafford W., Young G., Denman R., Pavia S., Nadurata V. Performance and Benefits of remote device follow-up with Carelink. Heart, Lung and Circulation 2009, 18(Suppl. 3):S267.
13. Ricci R., Morichelli L., Quarta L., Sassi A., Porfili A., Laudadio M.T., et al. Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace 2010, 12:674-679.
14. http://www.medicareaustralia.gov.au/provider/pubs/statistical-reporting.jsp.